Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDH1 | O75874 | 19/20 | 0.85 |
| ▸ | IDH2 | P48735 | 3/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22271258 | 0.96 | IDH1 (0.84) | IDH1IDH2 | |
| SCHEMBL21573286 | 0.96 | IDH1 (0.84) | IDH1IDH2 | |
| SCHEMBL16392940 | 0.92 | IDH1 (1.00) | IDH1IDH2 | |
| SCHEMBL16393255 | 0.87 | IDH1 (1.00) | IDH1IDH2 | |
| SCHEMBL16392941 | 0.87 | IDH1 (1.00) | IDH1IDH2 | |
| SCHEMBL21573380 | 0.87 | IDH1 (1.00) | IDH1IDH2 | |
| SCHEMBL16392772 | 0.87 | IDH1 (1.00) | IDH1IDH2 | |
| SCHEMBL16393305 | 0.87 | IDH1 (1.00) | IDH1IDH2 | |
| SCHEMBL29975911 | 0.87 | IDH1 (1.00) | IDH1IDH2 | |
| SCHEMBL29975706 | 0.87 | IDH1 (1.00) | IDH1IDH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111087353-B | Therapeutically active compounds and methods of use thereof | 法国施维雅药厂 | 2023-10-24 | — | — | CN | disclosed |
| EP-3686190-A1 | SYNTHESIS OF THERAPEUTICALLY ACTIVE COMPOUNDS | Agios Pharmaceuticals, Inc. (US) | 2020-07-29 | — | — | EP | disclosed |
| CN-111087353-A | Therapeutically active compounds and methods of use thereof | 安吉奥斯医药品有限公司 | 2020-05-01 | — | — | CN | disclosed |
| CN-105473560-B | Therapeutically active compounds and methods of use thereof | 安吉奥斯医药品有限公司 | 2020-01-17 | — | — | CN | disclosed |
| EP-3019483-B1 | THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE | AGIOS PHARMACEUTICALS INC (US) | 2019-11-20 | — | — | EP | disclosed |